Results 81 to 90 of about 1,561,331 (181)

Proportion of High-dose Antipsychotic Therapy and Prescription Pattern in Patients Diagnosed with Schizophrenia from a Tertiary Care Hospital in Nepal: An Observational Study

Journal of Nepal Medical Association
Introduction: High-dose antipsychotic therapy, defined as dosing exceeding 100% of the British National Formulary recommended  maximum daily dose, is associated with increased risk of adverse effects and is generally discouraged by clinical guidelines ...
Lujaw Ratna Tuladhar, Nidhi Rajeshwori Thapa, Jibeshwori Wagle, Suraj Sharma   +3 more
doaj   +1 more source

Case Report: Paralytic ileus as an early manifestation of evolving neuroleptic malignant syndrome in a patient receiving anti-psychotics

Frontiers in Medicine
Neuroleptic malignant syndrome (NMS) is an uncommon, but potentially life- threatening complication of antipsychotic therapy, primarily resulting from central dopaminergic blockade.
Balakrishnan Arivalagan, Pragathi Munnangi, Yashkumar Girdharlal Kamani, Jyoti Guglani, Angel Barrera, Krishna Singh, Makker Jasbir, Harish Patel, Misbahuddin Khaja   +8 more
doaj   +1 more source

Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort Study

Neurology and Therapy
Introduction We analysed the effects of antipsychotic drug prescribing in year 1 of treatment for psychosis on future weight gain over 5 years. Methods We studied how weight changed over 5 years after the first diagnosis of psychosis/schizophrenia ...
Adrian Heald, George Tilston, John Julian Warner-Levy, Loren Wilkins, Richard Williams, Toby Pillinger, William Deakin, Damien Longson, Lamiece Hassan, Caroline Dalton, Gavin P. Reynolds, Joseph Firth   +11 more
doaj   +1 more source

Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the sop first-onset psychosis study

, 2005
Subjects at their first psychotic episode show an enlarged volume of the pituitary gland, but whether this is due to hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, or to stimulation of the prolactin-secreting cells by antipsychotic treatment ...
Danese, A., Paola Dazzan, Morgan, Catherine, Flora Brudaglio, Pariante, C.M., Carmine M Pariante, Ken Orr, Morgan, K.D., Pariante, C.M.; id_orcid, Velakoulis, D., Gerard Hutchinson, Jones, P.B., Danese, Andrea; id_orcid, Murray, R.M., Dazzan, P.; id_orcid, Kevin D Morgan, Robin M Murray, Leff, J., Craig Morgan, Orr, K.G., Hutchinson, G., Orr, K., Pantelis, C., Paul Fearon, Dennis Velakoulis, Morgan, C., Christos Pantelis, Brudaglio, F., Fearon, P., Peter B Jones, Julian Leff, Dazzan, P., Andrea Danese   +32 more
core   +1 more source

Safety and tolerability of antipsychotics: focus on amisulpride

Drug, Healthcare and Patient Safety, 2010
Mario F Juruena1, Eduardo Pondé de Sena2, Irismar Reis de Oliveira31Stress and Affective Disorders Programme, Department of Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil ...
Mario F Juruena, Eduardo Pondé de Sena, Irismar Reis de Oliveira   +2 more
doaj  

Patient perspectives on antipsychotic treatments and their association with clinical outcomes

, 2010
Hong Liu-Seifert1, Olawale O Osuntokun1, Jenna L Godfrey2, Peter D Feldman11Lilly Research Laboratories, Indianapolis, IN, USA; 2Durham Veterans Affairs Medical Center, Durham, NC, USAAbstract: This analysis examined patient-reported attitudes toward ...
Olawale O Osuntokun, et al, Hong Liu-Seifert, Jenna L Godfrey   +3 more
core  

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents. [PDF]

Heliyon, 2020
Olasupo SB, Uzairu A, Shallangwa GA, Uba S.   +3 more
europepmc   +1 more source

Antipsychotic medication for people with first episode schizophrenia: an exploratory economic analysis of alternative treatment algorithms [PDF]

Available clinical evidence suggests that the newer antipsychotics are similar to conventional antipsychotics for positive symptom control. It has been suggested that they may also be superior for negative symptoms and side effects, but the evidence for ...
Linda Davies, Shon Lewis
core  

Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow-up study. [PDF]

Brain Behav, 2020
Zhuo C, Xiao B, Chen C, Jiang D, Li G, Ma X, Li R, Wang L, Xu Y, Zhou C, Lin X.   +10 more
europepmc   +1 more source

Antipsychotic prescription to identify delirium: results from two cohorts

, 2017
Kristin M Zimmerman,1 Allison M Paquin,2 James L Rudolph3,4 1Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA, 2Connecticut Center for Primary Care, ProHealth Physicians, Inc.
Zimmerman KM, Paquin AM, Rudolph JL
core